Myrbetriq ER 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FK4DZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,589
Award facts
- Contract value 100% obligated
- $14,589.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded September 3, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 90-count tablets of Myrbetriq ER 25 mg with a contract ceiling value of $14,589.42. The award is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, regularly fulfills federal medical procurement requirements across multiple therapeutic domains through competitive delivery orders with the DLA Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies supporting military and veteran healthcare systems. Myrbetriq (mirabegron) is commonly used in urology for overactive bladder treatment, and this order supports the Defense Health Agency's pharmaceutical supply requirements. The non-set-aside, competitively awarded delivery order demonstrates AmerisourceBergen's continued capability to meet federal standards for pharmaceutical procurement and timely delivery of critical medical products.
Quick answers
Who was awarded contract SPE2DB25FK4DZ?
SPE2DB25FK4DZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FK4DZ worth?
The government has obligated $14,589 on SPE2DB25FK4DZ.
Is contract SPE2DB25FK4DZ an order under another contract?
Yes. SPE2DB25FK4DZ is a delivery order under SPE2DB22D3019, an indefinite delivery contract.
Was contract SPE2DB25FK4DZ competed?
The extent of competition for SPE2DB25FK4DZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award